Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

Pharmaceutical Training International (PTI), the leading supplier of online and public, event-based training courses for the pharma, biotech and medical device sectors, has launched a range of game-based e-learning courses.

From Pharmaceutical Training International 2 Mar 2015

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).

28 Feb 2015

Perceived cost affects placebo response in Parkinson’s disease

Patients with Parkinson’s disease may gain a greater benefit from a placebo treatment if they believe it to be expensive, research suggests.

27 Feb 2015

TxCell invited to speak at largest US meeting for investors in emerging growth companies

In the presentation, Damian Marron will provide an overview of TxCell and its personalized T cell immunotherapy platform ASTrIA. Additional details will also be provided to institutional investors in one on one meetings at the conference.

27 Feb 2015

ChartSpan Medical Technologies raises $1.7 million in capital round

ChartSpan Medical Technologies announced it has successfully raised a capital round of $1.7 million dollars. Since becoming the most downloaded iPhone and iPad medical app in the U.S. in December, ChartSpan continues to disrupt healthcare with innovative technology empowering patients to manage their own healthcare records and information.

27 Feb 2015

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.

26 Feb 2015

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. The patches will be studied to evaluate their potential role as part of the worldwide efforts to eradicate polio.

25 Feb 2015

Patients battling sleep apnea find relief from Zzoma device

Thousands of patients in the U.S. and Europe battling positional obstructive sleep apnea (OSA) are finding relief from Zzoma, an FDA-cleared medical device designed by physicians at Sleep Specialists, LLC.

25 Feb 2015

Two Glenmark manufacturing facilities in India win Greentech Environment Gold Award - 2015

Two manufacturing facilities of Glenmark located in Goa and Nashik bagged the prestigious 'Greentech Environment Gold Award - 2015' for Excellence in Environment Management at a ceremony in Kolkata recently. Greentech Environment Awards are presented ever year to companies/units in India demonstrating the highest level of commitment to Environmental Management across different sectors.

25 Feb 2015

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray Incorporated and Lancaster General Health announced today that the first commercially available InCise Multileaf Collimator (MLC) for the CyberKnife M6 System has been received by Lancaster.

24 Feb 2015

Tekni-Plex Europe plans to acquire Gallazzi's Italian-based businesses

Tekni-Plex Europe NV is announcing today that its plan to acquire Gallazzi's Italian-based pharmaceutical blister film (Tradate, Varese, Lombardia) and adhesive tape substrate film (Gallarate, Varese, Lombardia) businesses has been approved by the Italian authorities supervising the sale.

23 Feb 2015

RepliCel submits CTA for RCS-01 study to treat patients suffering from aged, UV-damaged skin

RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced the submission of a Clinical Trial Application (CTA) to the German Competent Authority, the Paul-Ehrlich-Institut (PEI), requesting clearance to initiate a Phase 1 clinical trial investigating the use of RCS-01 to treat patients suffering from aged and UV-damaged skin.

23 Feb 2015

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

23 Feb 2015

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly emerging or re-emerging infectious disease. IDRI today announces it has received $4 million in funding from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to facilitate pandemic influenza preparedness in developing countries.

19 Feb 2015

Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

Quad Technologies Inc (“Quad”), developer of a novel separation technology, has formally announced its entry into the cell separation market.

19 Feb 2015

Novasep selected to commercially biomanufacture Celladon's Mydicar API

Novasep, a leading supplier of services and technologies for the life sciences industry, today announces that it has entered into an agreement with Celladon, a clinical-stage biotechnology company. Novasep will prepare to supply the drug substance for MYDICAR®.

19 Feb 2015

Particle sciences manufactures clinical supplies for Kinex’s glioblastom therapeutic

Particle Sciences, Inc (PSI), has completed the manufacturing of clinical supplies for the first in human studies of KX2-361 (KX02), Kinex Pharmaceuticals’ small molecule Src/pre-tublin inhibitor.

19 Feb 2015

TE Connectivity signs definitive agreement to acquire AdvancedCath

TE Connectivity Ltd., a world leader in connectivity, announced today that it has entered into a definitive agreement to acquire AdvancedCath for $190 million USD in cash.

19 Feb 2015

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

Globally, dental caries (the technical term for tooth decay) is the most prevalent non-communicable disease, affecting 80% of the global population. Healthy teeth support overall well-being, while dental caries can contribute to high levels of pain and anxiety, as well as leading to other medical problems.

18 Feb 2015

TSRI scientists develop new drug candidate against HIV

In a remarkable new advance against the virus that causes AIDS, scientists from the Jupiter, Florida campus of The Scripps Research Institute have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine.

18 Feb 2015

Manufacturing News and Research

Further Reading

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

Perceived cost affects placebo response in Parkinson’s disease

TxCell invited to speak at largest US meeting for investors in emerging growth companies

ChartSpan Medical Technologies raises $1.7 million in capital round

HeartWare International's revenue increases 38% to $73.2 million in Q4 2014

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

Patients battling sleep apnea find relief from Zzoma device

Two Glenmark manufacturing facilities in India win Greentech Environment Gold Award - 2015

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Tekni-Plex Europe plans to acquire Gallazzi's Italian-based businesses

RepliCel submits CTA for RCS-01 study to treat patients suffering from aged, UV-damaged skin

Hain Celestial Group announces acquisition of Belvedere International

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

Novasep selected to commercially biomanufacture Celladon's Mydicar API

Particle sciences manufactures clinical supplies for Kinex’s glioblastom therapeutic

TE Connectivity signs definitive agreement to acquire AdvancedCath

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

TSRI scientists develop new drug candidate against HIV

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News